Articles producció científica> Medicina i Cirurgia

Circulating microbiota-derived metabolites: a “liquid biopsy?

  • Dades identificatives

    Identificador: imarina:5880952
    Handle: https://hdl.handle.net/20.500.11797/imarina5880952
    Autors:
    Aragones, GemmaColom-Pellicer, MarinaAguilar, CarmenGuiu-Jurado, EstherMartinez, SalomeSabench, FatimaAntonio Porras, JoseRiesco, DavidDel Castillo, DanielRichart, CristobalAuguet, Teresa
    Resum:
    Non-alcoholic fatty liver disease (NAFLD) causes a wide spectrum of liver damage, from simple steatosis (SS) to cirrhosis. SS and non-alcoholic steatohepatitis (NASH) cannot be distinguished by clinical or laboratory features. Dysregulation of the gut microbiota is involved in NASH pathogenesis. The aim of this study was to assess the relationship between microbiota-derived metabolites and the degrees of NAFLD; also, to investigate whether these metabolites could be included in a panel of NASH biomarkers.We used liquid chromatography coupled to triple-quadrupole-mass spectrometry (LC-QqQ) analysis to quantify choline and its derivatives, betaine, endogenous ethanol, bile acids, short-chain fatty acids and soluble TLR4 in serum from women with normal weight (n?=?29) and women with morbid obesity (MO) (n?=?82) with or without NAFLD. We used real-time polymerase chain reaction (RT-PCR) analysis to evaluate the hepatic and intestinal expression level of all genes studied (TLR2, TLR4, TLR9, LXR?, SREBP1C, ACC1, FAS, PPAR?, CPT1?, CROT, SREBP2, ABCA1, ABCG1 and FXR in the liver; TLR2, TLR4, TLR5, TLR9, GLP-1R, DPP-4, FXR and PPAR? in the jejunum) in 82 women with MO with normal liver histology (NL, n?=?29), SS (n?=?32), and NASH (n?=?21).Hepatic FAS, TLR2, and TLR4 expression were overexpressed in NAFLD patients. TLR2 was overexpressed in NASH patients. In women with MO with NAFLD, we found upregulation of intestinal TLR9 expression and downregulation of intestinal FXR expression in women with NASH. Circulating TMAO, glycocholic acid and deoxycholic acid levels were significantly increased in NAFLD patients. Endogenous circulating ethanol levels were increased in NASH patients in comparison to those in SS patients.These findings suggest that the intestine participates in the

  • Altres:

    Autor segons l'article: Aragones, Gemma; Colom-Pellicer, Marina; Aguilar, Carmen; Guiu-Jurado, Esther; Martinez, Salome; Sabench, Fatima; Antonio Porras, Jose; Riesco, David; Del Castillo, Daniel; Richart, Cristobal; Auguet, Teresa
    Departament: Medicina i Cirurgia
    Autor/s de la URV: Aguilar Crespillo, Carmen Isabel / ARAGONÈS BARGALLÓ, GEMMA / Auguet Quintillà, Maria Teresa / Colom Pellicer, Marina / Del Castillo Déjardin, Daniel / GUIU JURADO, ESTHER / Martínez González, María Salomé / Porras Ledantes, Jose Antonio / Richart Jurado, Cristobal Manuel / Sabench Pereferrer, Fàtima
    Paraules clau: Good health and well-being
    Resum: Non-alcoholic fatty liver disease (NAFLD) causes a wide spectrum of liver damage, from simple steatosis (SS) to cirrhosis. SS and non-alcoholic steatohepatitis (NASH) cannot be distinguished by clinical or laboratory features. Dysregulation of the gut microbiota is involved in NASH pathogenesis. The aim of this study was to assess the relationship between microbiota-derived metabolites and the degrees of NAFLD; also, to investigate whether these metabolites could be included in a panel of NASH biomarkers.We used liquid chromatography coupled to triple-quadrupole-mass spectrometry (LC-QqQ) analysis to quantify choline and its derivatives, betaine, endogenous ethanol, bile acids, short-chain fatty acids and soluble TLR4 in serum from women with normal weight (n?=?29) and women with morbid obesity (MO) (n?=?82) with or without NAFLD. We used real-time polymerase chain reaction (RT-PCR) analysis to evaluate the hepatic and intestinal expression level of all genes studied (TLR2, TLR4, TLR9, LXR?, SREBP1C, ACC1, FAS, PPAR?, CPT1?, CROT, SREBP2, ABCA1, ABCG1 and FXR in the liver; TLR2, TLR4, TLR5, TLR9, GLP-1R, DPP-4, FXR and PPAR? in the jejunum) in 82 women with MO with normal liver histology (NL, n?=?29), SS (n?=?32), and NASH (n?=?21).Hepatic FAS, TLR2, and TLR4 expression were overexpressed in NAFLD patients. TLR2 was overexpressed in NASH patients. In women with MO with NAFLD, we found upregulation of intestinal TLR9 expression and downregulation of intestinal FXR expression in women with NASH. Circulating TMAO, glycocholic acid and deoxycholic acid levels were significantly increased in NAFLD patients. Endogenous circulating ethanol levels were increased in NASH patients in comparison to those in SS patients.These findings suggest that the intestine participates in the progression of NAFLD. Moreover, levels of certain circulating microbiota-related metabolites are associated with NAFLD severity and could be used as a "liquid biopsy" in the noninvasive diagnosis of NASH.
    Àrees temàtiques: Serviço social Saúde coletiva Psicología Nutrition and dietetics Nutrition & dietetics Nutrição Medicine (miscellaneous) Medicina iii Medicina ii Medicina i Interdisciplinar General medicine Farmacia Enfermagem Endocrinology, diabetes and metabolism Endocrinology & metabolism Educação física Ciências biológicas ii Ciências biológicas i Ciência de alimentos Biotecnología Astronomia / física
    Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 03070565
    Adreça de correu electrònic de l'autor: joseantonio.porras@urv.cat mariasalome.martinez@urv.cat danieldel.castillo@urv.cat marina.colom@urv.cat marina.colom@urv.cat fatima.sabench@urv.cat carmenisabel.aguilar@urv.cat carmenisabel.aguilar@urv.cat mariateresa.auguet@urv.cat
    Identificador de l'autor: 0000-0001-6418-1822 0000-0001-6185-2889 0000-0003-0456-3102 0000-0001-7024-7824 0000-0002-9262-8756 0000-0002-4440-562X 0000-0002-4440-562X https://orcid.org/0000-0003-0396-6428 0000-0003-0396-6428
    Data de publicació de l'article: 2019/08/06
    Pàgina final: 885
    Data d'alta del registre: 2024-12-21
    Volum de revista: 44
    Versió de l'article dipositat: info:eu-repo/semantics/acceptedVersion
    URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referència a l'article segons font original: International Journal Of Obesity. 44 (4): 875-885
    Referència de l'ítem segons les normes APA: Aragones, Gemma; Colom-Pellicer, Marina; Aguilar, Carmen; Guiu-Jurado, Esther; Martinez, Salome; Sabench, Fatima; Antonio Porras, Jose; Riesco, David; (2020). Circulating microbiota-derived metabolites: a “liquid biopsy?. International Journal Of Obesity, 44(4), 875-885. DOI: 10.1038/s41366-019-0430-0
    Entitat: Universitat Rovira i Virgili
    Any de publicació de la revista: 2020
    Pàgina inicial: 875
    Tipus de publicació: Journal Publications

  • Paraules clau:

    Endocrinology & Metabolism,Endocrinology, Diabetes and Metabolism,Medicine (Miscellaneous),Nutrition & Dietetics,Nutrition and Dietetics
    Good health and well-being
    Serviço social
    Saúde coletiva
    Psicología
    Nutrition and dietetics
    Nutrition & dietetics
    Nutrição
    Medicine (miscellaneous)
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Farmacia
    Enfermagem
    Endocrinology, diabetes and metabolism
    Endocrinology & metabolism
    Educação física
    Ciências biológicas ii
    Ciências biológicas i
    Ciência de alimentos
    Biotecnología
    Astronomia / física

  • Documents:

    DocumentPrincipal

  • Cerca a google

    Search to google scholar